4:12 PM
Nov 02, 2016
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Parkinson’s disease (PD)

In vitro studies identified a pyrazole-based COMT inhibitor that could help treat PD. Fragment-based screening, chemical synthesis and testing in an in vitro assay of mutant and wild-type COMT binding of pyrazole...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >